Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Azithromycin vs nbUVB in Pityriasis Lichenoides Chronica
NCT03831269Unknown
- Sponsor
- Cairo University
- Start
- Feb 2019
- Primary completion
- Jun 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, open-label trial of azithromycin in pityriasis lichenoides chronica (PLC) (2 arms), sponsored by Cairo University. Primary endpoint: Therapeutic efficacy of Azithromycin compared to nbUVB at 12 months. Status: unknown.
02
Drugs
azithromycin
03
Conditions
pityriasis lichenoides chronica (PLC)
Beyond the preview
Go deeper on NCT03831269.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03831269.